Research study Program year 2021 Source: CMS Open Payments

Phase IIB Dose Range Monotherapy with Population PK

Research payments

$407,349

43 payments

Through program year 2021, $407,349 in research payments was reported against Phase IIB Dose Range Monotherapy with Population PK, across 43 payments, paid by E.R. Squibb & Sons, L.L.C..

Paid by: E.R. Squibb & Sons, L.L.C.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$195,979	2
2020	Research	$60,722	2
2019	Research	$150,648	39

Breakdown

Who paid Research payments · program years 2019–2021

E.R. Squibb & Sons, L.L.C. $407,349 43 payments

Who received the money Research payments · program years 2019–2021

Jerome Barakos Diagnostic Radiology · San Francisco, CA $139,144 3 payments
Derk Purcell Diagnostic Radiology · San Francisco, CA $135,992 3 payments
Prisma Healthu2013midlands Organisation paid for research $7,414 1 payment
Advanced Neurology Specialists Pllc Organisation paid for research $6,266 1 payment
Stanford Stroke Center Organisation paid for research $6,213 1 payment
Guilford Neurologic Associates Organisation paid for research $5,670 1 payment
Vanderbilt University Medical Center Teaching hospital · TN $5,640 1 payment
University Hospitals Cleveland Medical Center Organisation paid for research $5,635 1 payment
University Of North Carolina At Chapel Hill Organisation paid for research $5,145 1 payment
Upmc Hamot Organisation paid for research $5,119 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.